4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide
C19H17BrClFN4O2 — CID 11178839
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide
4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide (PubChem CID 11178839) has the molecular formula C19H17BrClFN4O2 and a molecular weight of 467.73 g/mol. Its IUPAC name is 4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide.
Molecular Properties
| Compound Name | 4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide |
|---|---|
| PubChem CID | 11178839 |
| Molecular Formula | C19H17BrClFN4O2 |
| Molecular Weight | 467.73 g/mol |
| Exact Mass | 466.02 |
| IUPAC Name | 4-(5-bromo-3-chloro-2-fluorophenyl)-4-hydroxy-N-(1H-indazol-3-yl)piperidine-1-carboxamide |
| SMILES | O=C(Nc1n[nH]c2ccccc12)N1CCC(O)(c2cc(Br)cc(Cl)c2F)CC1 |
| InChI | InChI=1S/C19H17BrClFN4O2/c20-11-9-13(16(22)14(21)10-11)19(28)5-7-26(8-6-19)18(27)23-17-12-3-1-2-4-15(12)24-25-17/h1-4,9-10,28H,5-8H2,(H2,23,24,25,27) |
| InChIKey | UQKHELZZKBMNHU-UHFFFAOYSA-N |
| XLogP | 4.63 |
| TPSA | 81.25 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 467.73 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11178839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.